Characterizing Regionalization of Inflammatory Bowel Disease Hospitalizations and Operations in Washington State.
Elective surgery
Emergent hospitalizations
Inflammatory bowel disease
Minimally invasive surgery
Journal
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: Netherlands
ID NLM: 9706084
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
22
03
2023
accepted:
30
05
2023
medline:
27
11
2023
pubmed:
3
8
2023
entrez:
2
8
2023
Statut:
ppublish
Résumé
Hospitalizations for inflammatory bowel disease (IBD) are a major contributor of healthcare utilization. We assessed IBD hospitalizations and surgical operations in Washington State to characterize regionalization patterns. We identified a cohort of hospitalizations for Crohn's disease (CD) or ulcerative colitis (UC) from 2008 to 2019 using Washington State's Comprehensive Hospital Abstract Reporting System (CHARS). Hospitalizations were characterized by emergent or elective acuity and whether an operation or endoscopic procedure was performed. Facility volume and distance travelled by patients were used to determine regionalization. There were 20,494 IBD-related hospitalizations at 95 hospitals: 13,585 (66.3%) with CD and 6,909 (33.7%) with UC. Emergencies accounted for 78.2% of all IBD-related hospitalizations and did not differ between CD (78.3%) and UC (77.9%) (p = 0.54). Surgery was performed during 10.3% and endoscopy during 30.6% of emergent hospitalizations. 72.0% of emergent hospitalizations occurred at 22 facilities, while 71.1% of elective hospitalizations were concentrated at 9 facilities. Operations were performed during 78.5% of elective hospitalizations, and five hospitals performed 69% of all elective surgery. Laparoscopic surgery increased in both emergent (17% to 52%, p < 0.001) and elective operations (18% to 42%, p < 0.001) from 2008 to 2019. In Washington State, most IBD hospitalizations were emergent, which were decentralized and typically non-operative. By contrast, most elective admissions involved surgery and were centralized at a few high-volume centers. Further understanding the drivers behind IBD hospitalizations may help optimize emergent medical and elective surgical care at a state level.
Sections du résumé
BACKGROUND
Hospitalizations for inflammatory bowel disease (IBD) are a major contributor of healthcare utilization. We assessed IBD hospitalizations and surgical operations in Washington State to characterize regionalization patterns.
METHODS
We identified a cohort of hospitalizations for Crohn's disease (CD) or ulcerative colitis (UC) from 2008 to 2019 using Washington State's Comprehensive Hospital Abstract Reporting System (CHARS). Hospitalizations were characterized by emergent or elective acuity and whether an operation or endoscopic procedure was performed. Facility volume and distance travelled by patients were used to determine regionalization.
RESULTS
There were 20,494 IBD-related hospitalizations at 95 hospitals: 13,585 (66.3%) with CD and 6,909 (33.7%) with UC. Emergencies accounted for 78.2% of all IBD-related hospitalizations and did not differ between CD (78.3%) and UC (77.9%) (p = 0.54). Surgery was performed during 10.3% and endoscopy during 30.6% of emergent hospitalizations. 72.0% of emergent hospitalizations occurred at 22 facilities, while 71.1% of elective hospitalizations were concentrated at 9 facilities. Operations were performed during 78.5% of elective hospitalizations, and five hospitals performed 69% of all elective surgery. Laparoscopic surgery increased in both emergent (17% to 52%, p < 0.001) and elective operations (18% to 42%, p < 0.001) from 2008 to 2019.
CONCLUSIONS
In Washington State, most IBD hospitalizations were emergent, which were decentralized and typically non-operative. By contrast, most elective admissions involved surgery and were centralized at a few high-volume centers. Further understanding the drivers behind IBD hospitalizations may help optimize emergent medical and elective surgical care at a state level.
Identifiants
pubmed: 37532905
doi: 10.1007/s11605-023-05731-8
pii: S1091-255X(24)00031-3
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2493-2505Informations de copyright
© 2023. The Society for Surgery of the Alimentary Tract.
Références
Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. The Lancet. 2017;390(10114):2769-2778. https://doi.org/10.1016/S0140-6736(17)32448-0
doi: 10.1016/S0140-6736(17)32448-0
Ananthakrishnan AN, Kaplan GG, Ng SC. Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century. Clinical Gastroenterology and Hepatology. 2020;18(6):1252-1260. https://doi.org/10.1016/j.cgh.2020.01.028
doi: 10.1016/j.cgh.2020.01.028
pubmed: 32007542
Xu F, Liu Y, Wheaton AG, Rabarison KM, Croft JB. Trends and Factors Associated with Hospitalization Costs for Inflammatory Bowel Disease in the United States. Appl Health Econ Health Policy. 2019;17(1):77-91. https://doi.org/10.1007/s40258-018-0432-4
doi: 10.1007/s40258-018-0432-4
pubmed: 30259396
pmcid: 10498392
Kappelman MD, Rifas–Shiman SL, Porter CQ, et al. Direct Health Care Costs of Crohn’s Disease and Ulcerative Colitis in US Children and Adults. Gastroenterology. 2008;135(6):1907-1913. https://doi.org/10.1053/j.gastro.2008.09.012
doi: 10.1053/j.gastro.2008.09.012
pubmed: 18854185
Lichtenstein GR, Shahabi A, Seabury SA, et al. Lifetime Economic Burden of Crohn’s Disease and Ulcerative Colitis by Age at Diagnosis. Clinical Gastroenterology and Hepatology. 2020;18(4):889-897.e10. https://doi.org/10.1016/j.cgh.2019.07.022
doi: 10.1016/j.cgh.2019.07.022
pubmed: 31326606
King JA, Underwood FE, Panaccione N, et al. Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development. Lancet Gastroenterol Hepatol. 2019;4(4):287-295. https://doi.org/10.1016/S2468-1253(19)30013-5
doi: 10.1016/S2468-1253(19)30013-5
pubmed: 30765267
Tsai L, Ma C, Dulai PS, et al. Contemporary Risk of Surgery in Patients With Ulcerative Colitis and Crohn’s Disease: A Meta-Analysis of Population-Based Cohorts. Clinical Gastroenterology and Hepatology. 2021;19(10):2031-2045.e11. https://doi.org/10.1016/j.cgh.2020.10.039
Soriano CR, Powell CR, Chiorean M v, Simianu VV. Role of hospitalization for inflammatory bowel disease in the post-biologic era. World J Clin Cases. 2021;9(26):7632–7642. https://doi.org/10.12998/wjcc.v9.i26.7632
Ramos MC, Barreto JOM, Shimizu HE, Moraes APG de, Silva EN da. Regionalization for health improvement: A systematic review. PLoS One. 2020;15(12):e0244078. https://doi.org/10.1371/journal.pone.0244078
Simpson SH. Of Silos and Systems: The Issue of Regionalizing Health Care. Can J Hosp Pharm. 2011;64(4). https://doi.org/10.4212/cjhp.v64i4.1033
Cohen-Mekelburg S, Rosenblatt R, Gold S, et al. Fragmented Care is Prevalent Among Inflammatory Bowel Disease Readmissions and is Associated With Worse Outcomes. American Journal of Gastroenterology. 2019;114(2):276-290. https://doi.org/10.1038/s41395-018-0417-9
Borren NZ, Conway G, Tan W, et al. Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017;23(7):1234-1239. https://doi.org/10.1097/MIB.0000000000001133
Benchimol EI, Kuenzig ME, Bernstein CN, et al. Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study. Clin Epidemiol. 2018;Volume 10:1613-1626. https://doi.org/10.2147/CLEP.S178056
Rubin DT, Feld LD, Goeppinger SR, et al. The Crohnʼs and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access. Inflamm Bowel Dis. 2017;23(2):224-232. https://doi.org/10.1097/MIB.0000000000000994
Comprehensive Hospital Abstract Reporting System (CHARS): Washington State Department of Health. Accessed August 18, 2020. https://doh.wa.gov/dataandstatisticalreports/healthcareinwashington/hospitalandpatientdata/hospitaldischargedatachars
Simianu VV, Strate LL, Billingham RP, et al. The Impact of Elective Colon Resection on Rates of Emergency Surgery for Diverticulitis. Ann Surg. 2016;263(1):123-129. https://doi.org/10.1097/SLA.0000000000001053
Targan SR, Hanauer SB, van Deventer SJH, et al. A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn’s Disease. New England Journal of Medicine. 1997;337(15):1029-1036. https://doi.org/10.1056/NEJM199710093371502
Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis. New England Journal of Medicine. 2005;353(23):2462-2476. https://doi.org/10.1056/NEJMoa050516
Herrinton LJ, Liu L, Fireman B, et al. Time Trends in Therapies and Outcomes for Adult Inflammatory Bowel Disease, Northern California, 1998–2005. Gastroenterology. 2009;137(2):502-511. https://doi.org/10.1053/j.gastro.2009.04.063
Jeuring SFG, van den Heuvel TRA, Liu LYL, et al. Improvements in the Long-Term Outcome of Crohn’s Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort. American Journal of Gastroenterology. 2017;112(2):325-336. https://doi.org/10.1038/ajg.2016.524
Romano MJ, Segal JB, Pollack CE. The Association Between Continuity of Care and the Overuse of Medical Procedures. JAMA Intern Med. 2015;175(7):1148. https://doi.org/10.1001/jamainternmed.2015.1340
Cohen-Mekelburg S, Saini SD, Krein SL, et al. Association of Continuity of Care With Outcomes in US Veterans With Inflammatory Bowel Disease. JAMA Netw Open. 2020;3(9):e2015899. https://doi.org/10.1001/jamanetworkopen.2020.15899
Regueiro M, Click B, Holder D, Shrank W, McAnallen S, Szigethy E. Constructing an Inflammatory Bowel Disease Patient–Centered Medical Home. Clinical Gastroenterology and Hepatology. 2017;15(8):1148-1153.e4. https://doi.org/10.1016/j.cgh.2017.05.026
Regueiro M, Click B, Anderson A, et al. Reduced Unplanned Care and Disease Activity and Increased Quality of Life After Patient Enrollment in an Inflammatory Bowel Disease Medical Home. Clinical Gastroenterology and Hepatology. 2018;16(11):1777-1785. https://doi.org/10.1016/j.cgh.2018.04.007
Shah R, Wright E, Tambakis G, et al. Telehealth model of care for outpatient inflammatory bowel disease care in the setting of the <scp>COVID</scp> ‐19 pandemic. Intern Med J. 2021;51(7):1038-1042. https://doi.org/10.1111/imj.15168
Shah KP, Triana AJ, Gusdorf RE, et al. Demographic Factors Associated With Successful Telehealth Visits in Inflammatory Bowel Disease Patients. Inflamm Bowel Dis. 2022;28(3):358-363. https://doi.org/10.1093/ibd/izab068
Busby J, Tanberk J. FCC Reports Broadband Unavailable to 21.3 Million Americans, BroadbandNow Study Indicates 42 Million Do Not Have Access. https://broadbandnow.com/research/fcc-underestimates-unserved-by-50-percent .
Federal Communications Commission. 2020 Broadband Deployment Report.; 2020.
Julien HM, Eberly LA, Adusumalli S. Telemedicine and the Forgotten America. Circulation. 2020;142(4):312-314. https://doi.org/10.1161/CIRCULATIONAHA.120.048535
Gordon M, Sinopoulou V, Akobeng AK, Lakunina S, Gjuladin-Hellon T, Bracewell K. Remote care through telehealth for people with inflammatory bowel disease. Cochrane Database of Systematic Reviews. Published online April 15, 2021. https://doi.org/10.1002/14651858.CD014821
Law CCY, Sasidharan S, Rodrigues R, et al. Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations. Inflamm Bowel Dis. 2016;22(9):2149-2157. https://doi.org/10.1097/MIB.0000000000000870
Callahan MA, Christos PJ, Gold HT, Mushlin AI, Daly JM. Influence of Surgical Subspecialty Training on In-Hospital Mortality for Gastrectomy and Colectomy Patients. Ann Surg. 2003;238(4):629-639. https://doi.org/10.1097/01.sla.0000089855.96280.4a
Nguyen GC, Steinhart AH. The Impact of Surgeon Volume on Postoperative Outcomes After Surgery for Crohnʼs Disease. Inflamm Bowel Dis. 2014;20(2):301-306. https://doi.org/10.1097/01.MIB.0000438247.06595.b9
Nguyen GC, Nugent Z, Shaw S, Bernstein CN. Outcomes of Patients With Crohn’s Disease Improved From 1988 to 2008 and Were Associated With Increased Specialist Care. Gastroenterology. 2011;141(1):90-97. https://doi.org/10.1053/j.gastro.2011.03.050
Mathias H, Heisler C, Morrison, Julia, Currie B, Phalen-Kelly K, Jones J. Examining the Association Between Referral Quality, Wait Time and Patient Outcomes for Patients Referred to an IBD Specialty Program. J Can Assoc Gastroenterol. 2020;3(4):154–161. https://doi.org/10.1093/jcag/gwz002